We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Health body’s concern reflects heightened vigilance over signs of disease outbreaks since Covid pandemic
Also in this newsletter: Why tourists and residents are fighting over Rome’s sidewalks
A new crop of weight-loss drugs is disrupting markets as well as transforming waistlines
Royal College of GPs urges government to take action over ‘unsafe’ infrastructure ahead of Autumn Statement
FCA censures collapsed FTSE 100 company for publishing ‘materially inaccurate’ financial statements
NHS Providers chief warns of ‘sense of dread’ among staff ahead of winter as union remains locked in pay dispute
Pharmacy staff aim to form union after coming under pressure to make up for falling demand for jab
Wegovy found to have ‘quite profound’ effect on reducing risk of heart attacks, says pharma group
Efforts to protect women’s reproductive rights are helping Joe Biden’s party, strategists say
NAO says just £729mn from original £1.7bn budget may now be spent between 2022 and 2025
US and UK regulators say diabetes medication showed ‘significant’ weight loss benefits
Ecommerce giant aims to widen its reach into $4tn industry
Sale of Eugin Group marks latest bid by private equity to capitalise on demand for fertility services
Survey of 1,000 companies lays bare worries about impact of long NHS waiting lists on workforce productivity
Emerging research is challenging a widely held belief that new cases of the condition will rise exponentially as people live longer
Strains are particularly acute in areas of high deprivation
Failure to grant extra funding in Autumn Statement would be ‘self-destructive’, head of King’s Fund think-tank says
NHS has made ‘poor use’ of resources but government’s long-term staffing plan is ‘unfunded and uncosted’, committee finds
Anaesthetists resign from contracts with medical insurer as private sector picks up strain from NHS
It follows surge in popularity of Ozempic, which is often used for weight loss
A push into healthcare could well revive plans to sell the UK drugstore business
Some machines that help with restricted breathing at night under scrutiny because of risk of chemical exposure
FT research finds dangerously high bed occupancy levels and delays for A&E treatment
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Economic and political fallout from war distracts governments from health threats
International Edition
